NO20060261L - Tablett omfattende fluvastatin og karmellose kalsium - Google Patents

Tablett omfattende fluvastatin og karmellose kalsium

Info

Publication number
NO20060261L
NO20060261L NO20060261A NO20060261A NO20060261L NO 20060261 L NO20060261 L NO 20060261L NO 20060261 A NO20060261 A NO 20060261A NO 20060261 A NO20060261 A NO 20060261A NO 20060261 L NO20060261 L NO 20060261L
Authority
NO
Norway
Prior art keywords
caramelless
calcium
tablet containing
fluvastatin
containing fluvastatin
Prior art date
Application number
NO20060261A
Other languages
English (en)
Norwegian (no)
Inventor
Tomoyuki Uehara
Kenji Taguchi
Kenichi Kitaoka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20060261L publication Critical patent/NO20060261L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20060261A 2003-06-25 2006-01-18 Tablett omfattende fluvastatin og karmellose kalsium NO20060261L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
NO20060261L true NO20060261L (no) 2006-01-18

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060261A NO20060261L (no) 2003-06-25 2006-01-18 Tablett omfattende fluvastatin og karmellose kalsium

Country Status (21)

Country Link
US (1) US20090117181A1 (is)
EP (1) EP1641440B1 (is)
KR (1) KR20060030480A (is)
CN (1) CN1809342A (is)
AT (1) ATE471713T1 (is)
AU (1) AU2004251439B2 (is)
BR (1) BRPI0411855A (is)
CA (1) CA2529447A1 (is)
CO (1) CO5650224A2 (is)
DE (1) DE602004027808D1 (is)
EC (1) ECSP056238A (is)
IL (1) IL172531A0 (is)
IS (1) IS8249A (is)
MA (1) MA27889A1 (is)
MX (1) MXPA05013943A (is)
NO (1) NO20060261L (is)
NZ (1) NZ544119A (is)
RU (1) RU2361582C2 (is)
TN (1) TNSN05330A1 (is)
WO (1) WO2005000276A1 (is)
ZA (1) ZA200509930B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1825847A3 (en) * 2006-02-24 2008-01-23 Teva Pharmaceutical Industries Ltd Fluvastatin sodium pharmaceutical compositions
AU2011315555B2 (en) * 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
EP2698159A4 (en) 2011-04-12 2014-11-05 Sawai Seiyaku Kk PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
WO2001058491A1 (en) * 2000-02-10 2001-08-16 Takeda Chemical Industries, Ltd. Drug comprising combination
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
CA2424770A1 (en) * 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation

Also Published As

Publication number Publication date
NZ544119A (en) 2008-04-30
DE602004027808D1 (de) 2010-08-05
EP1641440B1 (en) 2010-06-23
EP1641440A1 (en) 2006-04-05
ZA200509930B (en) 2007-01-31
US20090117181A1 (en) 2009-05-07
KR20060030480A (ko) 2006-04-10
CO5650224A2 (es) 2006-06-30
IL172531A0 (en) 2006-04-10
RU2361582C2 (ru) 2009-07-20
TNSN05330A1 (en) 2007-07-10
CN1809342A (zh) 2006-07-26
ATE471713T1 (de) 2010-07-15
RU2006101889A (ru) 2007-08-10
MA27889A1 (fr) 2006-05-02
AU2004251439B2 (en) 2008-09-11
AU2004251439A1 (en) 2005-01-06
MXPA05013943A (es) 2006-02-24
IS8249A (is) 2006-01-20
BRPI0411855A (pt) 2006-08-29
ECSP056238A (es) 2006-04-19
CA2529447A1 (en) 2005-01-06
WO2005000276A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
CR7076S (es) Recipiente
NO20053248D0 (no) Kerosenblanding.
NO20041195L (no) Tablettmater.
NO20060261L (no) Tablett omfattende fluvastatin og karmellose kalsium
ZA200604874B (en) Pharmaceutical compositions
NL1025055A1 (nl) Verbeterd lampontwerp.
ES1052333Y (es) Cajon premarco.
TW200500081A (en) Novel rotaviruses and use thereof
ES1053053Y (es) Destoconador vertical.
ES1052590Y (es) Quiosco-consigna.
ES1053421Y (es) Linterna.
ES1053557Y (es) Luminaria vertical empotrable.
ES1051893Y (es) Alarma vecinal.
ITSS20020004A1 (it) Paella algherese.
MA25629A1 (fr) Reacteur : aero-hydro-electrique.
ITMI20020288A1 (it) Do.re.mi
ES1052131Y (es) Luminaria estanca mejorada.
ES1052628Y (es) Extintor instantaneo.
ES1053097Y (es) Envase-expositor mejorado.
ES1053652Y (es) Luminaria empotrable.
ES1052011Y (es) Espetero.
ES1052945Y (es) Contraventana.
ES1051605Y (es) Cromo-puzzle.
ES1052654Y (es) Cubitera.
ES1051110Y (es) Caja-palet.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application